Neuronetics (STIM) Operating Income Growth (1y) (2018 - 2026)
Neuronetics (STIM) Operating Income Growth (1y) (2018 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Op. Inc Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.07 Bn | 193.46 Bn | 7.27 Bn | -17.50% |
| 2 | Stryker | 127.90 Bn | 124.43 Bn | 4.50 Bn | 49.06% |
| 3 | Medtronic | 118.84 Bn | 109.62 Bn | 6.41 Bn | 30.43% |
| 4 | Boston Scientific | 73.33 Bn | 72.79 Bn | 3.85 Bn | 43.83% |
| 5 | Edwards Lifesciences | 51.93 Bn | 47.68 Bn | 1.35 Bn | 24.81% |
| 6 | Dexcom | 34.46 Bn | 32.51 Bn | 830.00 Mn | 49.72% |
| 7 | GE HealthCare Technologies | 33.91 Bn | 31.81 Bn | 2.18 Bn | 13.00% |
| 8 | Koninklijke Philips | 26.36 Bn | 23.04 Bn | 4.55 Bn | 57.74% |
| 9 | Steris | 23.12 Bn | 22.64 Bn | 684.20 Mn | 16.18% |
| 10 | Neuronetics | 225.60 Mn | 206.17 Mn | 21.22 Mn | 81.37% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 81.37% |
| Mar 31, 2026 | 18.33% |
| Dec 31, 2025 | 56.04% |
| Sep 30, 2025 | 5.27% |
| Jun 30, 2025 | 5.28% |
| Mar 31, 2025 | -60.58% |
| Dec 31, 2024 | -159.14% |
| Sep 30, 2024 | 12.88% |
| Jun 30, 2024 | -15.76% |
| Mar 31, 2024 | 30.77% |
| Dec 31, 2023 | 42.71% |
| Sep 30, 2023 | -19.01% |
| Jun 30, 2023 | 24.98% |
| Mar 31, 2023 | 2.25% |
| Dec 31, 2022 | -11.84% |
| Sep 30, 2022 | -3.79% |
| Jun 30, 2022 | -49.24% |
| Mar 31, 2022 | -46.69% |
| Dec 31, 2021 | -159.74% |
| Sep 30, 2021 | -196.29% |